Inspire Medical Ownership
| INSP Stock | USD 164.92 2.17 1.33% |
Shares in Circulation | First Issued 2017-03-31 | Previous Quarter 31 M | Current Value 31 M | Avarage Shares Outstanding 22.2 M | Quarterly Volatility 10 M |
Inspire |
Inspire Stock Ownership Analysis
About 98.0% of the company shares are owned by institutional investors. The company last dividend was issued on the January 9, 2008. Inspire Medical Systems had 1:10 split on the September 13, 2002. Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea in the United States and internationally. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. Inspire Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 485 people. To learn more about Inspire Medical Systems call Timothy Herbert at (844) 672-4357 or check out https://www.inspiresleep.com.Besides selling stocks to institutional investors, Inspire Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Inspire Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Inspire Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Inspire Medical Quarterly Liabilities And Stockholders Equity |
|
Inspire Medical Insider Trades History
Roughly 2.0% of Inspire Medical Systems are currently held by insiders. Unlike Inspire Medical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Inspire Medical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Inspire Medical's insider trades
Inspire Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Inspire Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inspire Medical Systems backward and forwards among themselves. Inspire Medical's institutional investor refers to the entity that pools money to purchase Inspire Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Hhg Plc | 2024-12-31 | 567.3 K | Macquarie Group Ltd | 2024-12-31 | 537.6 K | Jpmorgan Chase & Co | 2024-12-31 | 519.5 K | Geode Capital Management, Llc | 2024-12-31 | 486.3 K | Artisan Partners Limited Partnership | 2024-12-31 | 450.2 K | Champlain Investment Partners, Llc | 2024-12-31 | 444.4 K | Aqr Capital Management Llc | 2024-12-31 | 438.8 K | Timessquare Capital Management, Llc | 2024-12-31 | 433.8 K | Frontier Capital Management Co Inc | 2024-12-31 | 418.9 K | Blackrock Inc | 2024-12-31 | 4.2 M | Vanguard Group Inc | 2024-12-31 | 3.3 M |
Inspire Medical Systems Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inspire Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inspire Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Inspire Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Inspire Medical Outstanding Bonds
Inspire Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Inspire Medical Systems uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Inspire bonds can be classified according to their maturity, which is the date when Inspire Medical Systems has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Inspire Medical Corporate Filings
| 18th of March 2025 Other Reports | ViewVerify | |
F4 | 5th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 24th of February 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
| 12th of February 2025 Other Reports | ViewVerify |
Pair Trading with Inspire Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inspire Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspire Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Inspire Stock
Moving against Inspire Stock
| 0.69 | MNDR | Mobile health Network | PairCorr |
| 0.53 | AZN | AstraZeneca PLC ADR | PairCorr |
| 0.51 | LUCD | Lucid Diagnostics | PairCorr |
| 0.37 | LUNG | Pulmonx Corp | PairCorr |
| 0.36 | INMD | InMode | PairCorr |
The ability to find closely correlated positions to Inspire Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inspire Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inspire Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inspire Medical Systems to buy it.
The correlation of Inspire Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inspire Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inspire Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inspire Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.